The UBS MSCI Switzerland 20/35 UCITS ETF CHF acc is a large exchange-traded fund managed by UBS ETF, domiciled in Luxembourg and launched on 31 October 2013. It seeks to replicate the price and yield performance of the MSCI Switzerland 20/35 Index through physical full replication, investing in large and mid-cap Swiss stocks with proportionate weightings to index components. Denominated in Swiss Francs (CHF) and currency unhedged, this accumulating ETF reinvests dividends rather than distributing them, enhancing share price growth over time. With assets under management exceeding 2,340 million Euros and a total expense ratio of 0.20% per annum, it offers cost-efficient exposure to the Swiss equity market. Notable holdings include leading firms like Roche Holding AG, underscoring its focus on prominent Swiss companies across sectors such as pharmaceuticals, finance, and consumer goods. Compliant with UCITS regulations, the ETF plays a key role in providing investors targeted access to Switzerland's stable and diversified economy, emphasizing long-only strategy without sustainability focus.